Navidea Biopharmaceuticals, Inc. announced that Board of Directors, Dana J. Moss, Jill Bieker Stefanelli, and Joshua Wilson resigned their positions on the Company?s board of directors effective May 7, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +19,900.00% | -99.67% | -99.64% |
Jun. 21 | Navidea Biopharmaceuticals, Inc. Announces Board Resignations | CI |
2023 | Navidea Biopharmaceuticals, Inc. announced that it has received $0.75 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-99.64% | 20K | |
+23.13% | 52.73B | |
+37.49% | 39B | |
-8.73% | 38.52B | |
+28.09% | 30.38B | |
-12.26% | 26.39B | |
+10.57% | 26.08B | |
+45.05% | 14.15B | |
+32.23% | 12.6B | |
-6.56% | 11.51B |
- Stock Market
- Equities
- NAVB Stock
- News Navidea Biopharmaceuticals, Inc.
- Navidea Biopharmaceuticals, Inc. Announces Board Resignations